{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:12:18Z","timestamp":1793301138884,"version":"4.5.0"},"reference-count":45,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T00:00:00Z","timestamp":1341273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Early Intervention Psych"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>Clozapine is used in children and adolescents to treat early onset schizophrenia, but data on efficacy and on the plasma clozapine concentrations attained are limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We studied data from a clozapine therapeutic drug monitoring (<jats:styled-content style=\"fixed-case\">TDM<\/jats:styled-content>) service, patients in the <jats:styled-content style=\"fixed-case\">UK<\/jats:styled-content> and Eire aged &lt;18\u2009years, 1994\u20132010. Multiple linear regression analysis was performed to investigate the relationship between plasma clozapine concentration and dose, age, sex, body weight, plasma clozapine:norclozapine ratio (clozapine metabolic ratio (<jats:styled-content style=\"fixed-case\">MR<\/jats:styled-content>)) and smoking habit.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 1408 samples from 454 patients, 267 (59%) males aged at time of first sample (median = 17; range = 8\u201317 years) and 187 (41%) females aged 16 (10\u201317)\u2009years. The plasma clozapine concentration was &lt;0.35\u2009mg\u2009L<jats:sup>\u22121<\/jats:sup> in 36%, and \u22650.60\u2009mg\u2009L<jats:sup>\u22121<\/jats:sup> in 31% of samples (6.4% samples \u22651.0\u2009mg\u2009L<jats:sup>\u22121<\/jats:sup>). Although plasma clozapine was broadly related to prescribed dose, there was much variation: 10% of samples had plasma clozapine &gt;0.60\u2009mg\u2009L<jats:sup>\u22121<\/jats:sup> at prescribed clozapine doses of 50\u2013150\u2009mg\u2009d<jats:sup>\u22121<\/jats:sup> (66% &lt;0.35\u2009mg\u2009L<jats:sup>\u22121<\/jats:sup>), while 12% of samples had plasma clozapine &lt;0.35\u2009mg\u2009L<jats:sup>\u22121<\/jats:sup> at doses \u2265650\u2009mg\u2009d<jats:sup>\u22121<\/jats:sup> (62% &gt;0.6\u2009mg\u2009L<jats:sup>\u22121<\/jats:sup>). The covariates studied in the 16\u201317\u2010year\u2010olds had proportionately similar influences to those observed in adults. Together they explained 48% of the variance observed in plasma clozapine, with dose, smoking habit, MR and sex being major influences. In the younger patients, there were very few smokers, and the influence of sex did not reach statistical significance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>As in adults, clozapine <jats:styled-content style=\"fixed-case\">TDM<\/jats:styled-content> may help in assessing adherence and in dose adjustment, for example if smoking habit changes.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1751-7893.2012.00374.x","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T04:09:16Z","timestamp":1341288556000},"page":"122-130","source":"Crossref","is-referenced-by-count":47,"title":["Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged &lt;18\u2009years: data from a therapeutic drug monitoring service, 1994\u20132010"],"prefix":"10.1111","volume":"7","author":[{"given":"Lewis","family":"Couchman","sequence":"first","affiliation":[{"name":"Toxicology Unit Department of Clinical Biochemistry King's College Hospital NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally V.J.","family":"Bowskill","sequence":"additional","affiliation":[{"name":"Toxicology Unit Department of Clinical Biochemistry King's College Hospital NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Handley","sequence":"additional","affiliation":[{"name":"Toxicology Unit Department of Clinical Biochemistry King's College Hospital NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine X.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies Institute of Psychiatry King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Toxicology Unit Department of Clinical Biochemistry King's College Hospital NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,7,3]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7610.1986.tb00624.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.2165\/11585350-000000000-00000"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(02)00429-2"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-007-0621-4"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e32833b027e"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000251618.25248.00"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.59.5.507"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7893.2009.00124.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.08050756"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.9.3.459"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830120020005"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.7.721"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2007.0089"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.04.043"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.982"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540260801889179"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2009.04.008"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2010.07.002"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7893.2011.00262.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1089\/104454602760219126"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.16.308"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-006-0602-7"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-008-0105-9"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.2165\/11592020-000000000-00000"},{"key":"e_1_2_6_26_1","first-page":"218","article-title":"Evidence\u2010based recommendations for monitoring safety of second generation antipsychotics in children and youth","volume":"20","author":"Pringsheim T","year":"2011","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2011.0015"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.8.1439"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/chi.0b013e31812eed10"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1181"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1192\/pb.29.10.377"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200404000-00012"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200509000-00003"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.3109\/9780203092835"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32819f8f17"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000106221.36344.4d"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181dad1fb"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181f0a1a2"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/004982598238895"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.014456"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1004591"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.10.008"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370705200708"},{"key":"e_1_2_6_44_1","volume-title":"Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care","author":"National Institute for Health and Clinical Excellence","year":"2009"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.11.19"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-20195-0_3"}],"container-title":["Early Intervention in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7893.2012.00374.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1751-7893.2012.00374.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:58:02Z","timestamp":1697331482000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-7893.2012.00374.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/j.1751-7893.2012.00374.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1751-7893.2012.00374.x","archive":["Portico"],"relation":{},"ISSN":["1751-7885","1751-7893"],"issn-type":[{"value":"1751-7885","type":"print"},{"value":"1751-7893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,3]]}}}